These categories are especially important when the routine includes retinal, retinol, exfoliating acids, or other concentrated treatments
A 15% body weight reduction the STEP-1 semaglutide benchmark is associated with type 2 diabetes remission in 37% of treated patients, 28% reduction in hypertension medication requirements, 25% improvement in sleep apnea severity, and MASH progression reversal
The same comprehensive review also reported gas in 12% of participants in one of the analyzed cohorts, indicating that frequency can vary with study population and dosing, as reported in Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes
Schedule a consultation to find out whether weight loss injections are a safe and appropriate option for you
3 GLP-1 alternatives to consider If you find youre not responding to GLP-1s, or if you are seeing results and want to build on them, Dr